Moderna (MRNA) Tops Q1 EPS by 48c

Moderna (NASDAQ: MRNA) reported Q1 EPS of ($3.07), $0.48 better than the analyst estimate of ($3.55). Revenue for the quarter came in at $167 billion versus the consensus estimate of $94.28 million.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• Investing.com’s stocks of the week